Completely resected N1 non?small cell lung cancer: Factors affecting recurrence and long-term survival
August 31st, 2006
N1 disease in non-small cell lung cancer represents a heterogeneous patient subgroup with a 5-year survival of approximately 40%. Few reports have evaluated the correlation between N1 disease and tumor recurrence or which subgroup of patients would most benefit from adjuvant chemotherapy.